BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND LDH AND Clinical Outcome
22 results:

  • 1. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
    Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
    Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients - results of the PALG study 'PolAZA'.
    Mądry K; Lis K; Tukiendorf A; Szwedyk P; Kapelko-Słowik K; Subocz E; Gołos A; Makowska W; Masternak A; Kopińska A; Czemerska M; Zawadzka-Leska S; Rusicka P; Drozd-Sokołowska J; Wiater E; Hołojda J; Pogłódek B; Centkowski P; Waszczuk-Gajda A; Machowicz R; Hałka J; Czerw T; Basak G; Dwilewicz-Trojaczek J
    Hematology; 2021 Dec; 26(1):556-564. PubMed ID: 34384334
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
    Liu K; Wu Z; Chu J; Yang L; Wang N
    Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Primary plasma cell leukemia. Report of five cases].
    Mendoza MG; Valladares X; Roa M; Reyes M; Osorio R; Undurraga MS; Legües ME; Cabrera ME; Peña C
    Rev Med Chil; 2019; 147(1):18-23. PubMed ID: 30848760
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
    Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X
    Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its clinical outcome.
    Tawfeek GA; Alhassanin S
    Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid leukemia and Influence on clinical outcome.
    Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
    Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic leukemia Associated with Unfavorable Prognosis.
    Grywalska E; Roliński J; Pasiarski M; Korona-Glowniak I; Maj M; Surdacka A; Grafka A; Stelmach-Gołdyś A; Zgurski M; Góźdź S; Malm A; Grabarczyk P; Starosławska E
    PLoS One; 2015; 10(10):e0140178. PubMed ID: 26460692
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D Insufficiency in B-Chronic Lymphoid leukemia at the Time of Disease Presentation in Pakistan.
    Parveen S; Zeeshan R; Sultan S; Irfan SM
    Asian Pac J Cancer Prev; 2015; 16(14):5983-6. PubMed ID: 26320484
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
    Molica S; Digiesi G; Mirabelli R; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Morabito F; Neri A; Baldini L; Ferrarini M
    Eur J Haematol; 2009 Sep; 83(3):208-14. PubMed ID: 19459926
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma].
    Usnarska-Zubkiewicz L; Mazur G; Wróbel T; Poreba M; Kuliczkowski K
    Pol Arch Med Wewn; 2003 Jul; 110(1):719-24. PubMed ID: 14682206
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic significance of multidrug resistance protein in adult T-cell leukemia.
    Ohno N; Tani A; Chen ZS; Uozumi K; Hanada S; Akiba S; Ren XQ; Furukawa T; Sumizawa T; Arima T; Akiyama SI
    Clin Cancer Res; 2001 Oct; 7(10):3120-6. PubMed ID: 11595704
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. TP53 deletions but not trisomy 12 are adverse in B-cell lymphoproliferative disorders.
    Shaw GR; Kronberger DL
    Cancer Genet Cytogenet; 2000 Jun; 119(2):146-54. PubMed ID: 10867151
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CD45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia.
    Suzuki M; Matsuoka H; Yamashita K; Maeda K; Kawano K; Uno H; Tsubouchi H
    Leuk Lymphoma; 1998 Feb; 28(5-6):583-90. PubMed ID: 9613989
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
    Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
    Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Serum ldh value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly.
    Ferrara F; Mirto S
    Br J Haematol; 1996 Mar; 92(3):627-31. PubMed ID: 8616027
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.